A Healthcare Financial Management Association survey published this week found that 27% of US healthcare organizations are actively deploying AI at scale across multiple revenue cycle functions. Another 53% are conducting pilots. The survey, which polled 95 healthcare finance professionals in February 2026, was reported by HFMA as part of its “Revenue Cycle of the Future” research series.

The numbers indicate that healthcare AI has crossed a threshold: more organizations are deploying or piloting (80% combined) than are still evaluating or waiting.

Where AI Is Landing First

The deployments cluster around operational and administrative functions, not clinical decision-making. According to HFMA, front-end operations are seeing AI applications in self-healing data systems that identify and correct missing patient information in real time before claim submission. Predictive analytics flag high-risk accounts during scheduling. Conversational AI handles patient financial inquiries and deflects calls.

Mid-cycle, the focus is on ambient documentation and autonomous medical coding. AI analyzes clinical documentation and assigns codes, compressing a process that once took days into hours. Back-end functions target automated appeals for claim denials.

This operational focus aligns with what Cloudforce observed at HIMSS 2026: “The use cases being deployed right now are operational. Ambient listening that cuts documentation time. Phone agents are replacing broken phone trees. Multi-agent workflows are tearing through administrative backlogs.”

The Revenue Cycle Market

The US revenue cycle management market totals approximately $90.6 billion today and is projected to reach nearly $308 billion by 2030, according to HFMA’s cited industry estimates. McKinsey & Co. projects that AI in the revenue cycle could reduce cost to collect by 30% to 60%, with faster cash realization and a workforce redirected from administrative tasks to patient-facing work.

Mayo Clinic is building what it describes as a “pizza tracker” for prior authorization, giving every stakeholder real-time visibility into a process that currently requires multiple phone calls and emails. “We know we have to decrease cost to collect, and technology is a major play for how we can do that,” Nikki Harper, chair of revenue cycle analytics, automation, and diversified revenue at Mayo Clinic, told HFMA.

Readiness Gap

The deployment numbers obscure a workforce readiness problem. Only 7% of surveyed leaders described their teams as “very prepared” for the revenue cycle of the future. Another 44% said “somewhat prepared.” The rest are not ready.

“It’s the most exciting time to be alive in revenue cycle,” said Candice Powers, chief revenue officer at USA Health. “But my staff are also feeling that pressure. Staff can feel the tension. Staff can feel the urgency with which we’re being asked to act,” according to the HFMA report.

The Compliance Constraint

Healthcare is the most regulated vertical adopting AI agents at production scale. Every automated coding decision, every patient data correction, and every claim submission is subject to HIPAA, CMS billing rules, and payer-specific requirements. The HIMSS 2026 conference made this explicit: accuracy requirements in healthcare exceed those in any other industry, and even small amounts of friction can undermine trust and adoption.

For agent builders, healthcare adoption at 27% deployment represents a market signal. The vertical that demands the most from governance, auditability, and accuracy is moving. If agents can pass healthcare’s compliance bar, the enterprise adoption curve in less-regulated industries will follow.